Intravitreal antiglaucoma treatment: refractive changes and retinal effects in rats
To evaluate the effect of two extended-release intravitreal (IV) hypopressure and neuroprotective treatments on refractive error and the neuroretina in rat eyes with chronic glaucoma. Cohort study. A total of 192 Long–Evans rat right eyes were analyzed: 42 healthy, 25 with glaucoma induced by episcleral vein sclerosis (G-evs), 60 G-evs treated with a single IV brimonidine–Laponite injection (G-evs–Brimonidine), 45 with glaucoma induced by anterior chamber microspheres (G-Ms), and 20 G-Ms treated with two IV latanoprost microsphere injections (G-Ms–Latanoprost). Assessments included intraocular pressure (IOP, rebound tonometry), retinal ganglion cell (RGC) function (electroretinography), diopter power, and neuroretinal structure (peripapillary retinal nerve fiber layer [pRNFL], RGC layer, and whole retina by optical coherence tomography) over 24 weeks. IOP, Latency and amplitude of electroretinography, diopters, thicknesses of the retinal layers. IV-treated glaucomatous eyes showed significantly lower IOP: G-evs–Brimonidine and G-Ms–Latanoprost vs. healthy eyes, and higher ERG b-wave amplitudes (both p < 0.001). All glaucomatous eyes exhibited dioptric power loss vs. healthy. G-evs–Brimonidine stabilized refraction and preserved RGC layer thickness (both p < 0.05). Conversely, G-Ms–Latanoprost caused greater myopization ( p = 0.011) but increased central retinal volume ( p < 0.001) and pRNFL thickness, exceeding even healthy eyes ( p = 0.001). Extended-release IV brimonidine and latanoprost lowered IOP and improved neuroretinal function and structure. A single IV brimonidine injection stabilized refraction and preserved RGC integrity, whereas repeated IV latanoprost injections induced myopization while enhancing central retinal and pRNFL thickness. These findings suggest that sustained-release IV therapy exerts both hypopressure and neuroprotective effects, while repeated injections may also modify ocular refractive status in glaucomatous eyes.
Authors
- Elena García‐Martín (ORCID: https://orcid.org/0000-0001-6258-2489)
- Silvia Méndez-Martínez (ORCID: https://orcid.org/0000-0001-6072-1545)
- María Jesús Rodrigo (ORCID: https://orcid.org/0000-0002-4009-3075)
- Inés Munuera (ORCID: https://orcid.org/0000-0002-1502-641X)
- Teresa Martínez (ORCID: https://orcid.org/0000-0002-8891-0417)
- Manuel Subías
- Luis Pablo
- Javier J. Bermúdez-Cervilla
- Claudia Hernández-Barahona
Institutions
- Universidad de Zaragoza (ES)
- Hospital Universitario Miguel Servet (ES)
- Instituto de Investigación Sanitaria Aragón (ES)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1038/s41598-026-74370-1
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministerio de Ciencia e Innovación
- Universidad de Zaragoza
- Gobierno de Aragón
- Instituto de Salud Carlos III
- European Regional Development Fund
- Agencia Estatal de Investigación